We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUR icon
1076
Murphy Oil
MUR
$4.78B
$53K ﹤0.01%
2,271
+661
+41% +$20.3K
STNG icon
1077
CALL
Scorpio Tankers
STNG
$3.81B
$53K ﹤0.01%
+3,000
New +$55.9K
NSTG
1078
DELISTED
NanoString Technologies, Inc.
NSTG
$53K ﹤0.01%
+3,544
New +$56.2K
ACIA
1079
DELISTED
Acacia Communications Inc
ACIA
$53K ﹤0.01%
+1,387
New +$56K
MANH icon
1080
Manhattan Associates
MANH
$11.4B
$52K ﹤0.01%
+1,219
New +$57.7K
MMS icon
1081
Maximus
MMS
$3.1B
$52K ﹤0.01%
+806
New +$53K
CHA
1082
DELISTED
China Telecom Corporation, LTD
CHA
$52K ﹤0.01%
+1,018
New +$51.1K
VXX
1083
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$52K ﹤0.01%
1,100
+700
+175% +$25.9K
BHC icon
1084
Bausch Health
BHC
$2.34B
$51K ﹤0.01%
2,760
+1,043
+61% +$24.8K
CVLT icon
1085
Commault Systems
CVLT
$5.61B
$51K ﹤0.01%
+858
New +$50.6K
IMO icon
1086
Imperial Oil
IMO
$60.4B
$51K ﹤0.01%
+2,000
New +$60.8K
VPG icon
1087
Vishay Precision Group
VPG
$914M
$51K ﹤0.01%
1,678
+1,031
+159% +$33.9K
CHRW icon
1088
PUT
C.H. Robinson
CHRW
$17.5B
$50K ﹤0.01%
600
TDOC icon
1089
PUT
Teladoc Health
TDOC
$1.3B
$50K ﹤0.01%
1,000
+900
+900% +$55.1K
VLGEA icon
1090
Village Super Market
VLGEA
$639M
$50K ﹤0.01%
+1,862
New +$48.6K
CYBR
1091
DELISTED
CyberArk
CYBR
$49K ﹤0.01%
657
+431
+191% +$30.8K
HNI icon
1092
HNI Corp
HNI
$3.59B
$49K ﹤0.01%
+1,375
New +$52.2K
OPRX icon
1093
OptimizeRx
OPRX
$133M
$49K ﹤0.01%
4,505
+4,356
+2,923% +$64.4K
R icon
1094
Ryder
R
$10.1B
$49K ﹤0.01%
1,015
-219
-18% -$12.6K
SABR icon
1095
Sabre
SABR
$835M
$49K ﹤0.01%
2,285
+956
+72% +$23.1K
TNET icon
1096
TriNet
TNET
$3.14B
$49K ﹤0.01%
+1,162
New +$53.5K
ULTA icon
1097
CALL
Ulta Beauty
ULTA
$24.3B
$49K ﹤0.01%
200
BG icon
1098
CALL
Bunge Global
BG
$20.8B
$48K ﹤0.01%
+900
New +$55.6K
MTB icon
1099
M&T Bank
MTB
$36.2B
$48K ﹤0.01%
334
-708
-68% -$113K
OFIX icon
1100
Orthofix Medical
OFIX
$419M
$48K ﹤0.01%
907
+775
+587% +$44.1K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.